Search results
Results from the WOW.Com Content Network
For symptomatic bradycardia, the usual dosage is 0.5 to 1 mg IV push; this may be repeated every 3 to 5 minutes, up to a total dose of 3 mg (maximum 0.04 mg/kg). [23] Atropine is also useful in treating second-degree heart block Mobitz type 1 (Wenckebach block), and also third-degree heart block with a high Purkinje or AV-nodal escape rhythm.
Difenoxin is a Schedule I drug by itself in the US; the combination with atropine is in the less-restrictive category Schedule IV on account of the adulterant (the practice of making opioids more easily available by including an abuse-deterring adulterating agent is standard practice in the United States). Pure difenoxin, in Schedule I, has a ...
Actions of atenolol include the reduction in myocardial contractility and heart rate, hence producing the effect of lowering blood pressure and cardiac output. [14] Side effects of atenolol include cold extremities and exacerbation of cardiac failure, hence this drug is not suitable for patients with heart failure. [14]
But, due to feedback regulation of the vasomotor center, there is a fall in blood pressure due to vasodilation. Important [ 5 ] muscarinic antagonists include atropine , hyoscyamine , hyoscine butylbromide and hydrobromide , ipratropium , tropicamide , cyclopentolate , pirenzepine and scopalamine .
Class IV agents affect calcium channels and the AV node. Class V agents work by other or unknown mechanisms. With regard to management of atrial fibrillation, classes I and III are used in rhythm control as medical cardioversion agents, while classes II and IV are used as rate-control agents.
Transvenous cardiac pacing (TVP), [1] also called endocardial pacing, is a potentially life-saving intervention used primarily to correct profound bradycardia.It can be used to treat symptomatic bradycardias that do not respond to transcutaneous pacing or to drug therapy.
Examples of sympathomimetic effects include increases in heart rate, force of cardiac contraction, and blood pressure. [1] The primary endogenous agonists of the sympathetic nervous system are the catecholamines (i.e., epinephrine [adrenaline], norepinephrine [noradrenaline], and dopamine), which function as both neurotransmitters and hormones.
The practice began declining during the 1970s as more reliable delivery methods (i.e., intravenous, endotracheal, and intraosseous) came into use. Around that time, studies revealed that intravenous injections were equally effective and were less prone to risks and complications.